跳至主要内容
临床试验/CTRI/2021/02/031377
CTRI/2021/02/031377已完成2 期

Evaluation of efficacy of bee pollen in treatment of oral submucous fibrosis patients: A randomized clinical drug trial

Dr Divya Dube0 个研究点目标入组 96 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Clinically diagnosed grade I. grade II, grade III, oral submucous fibrosis patients according to Khanna and Andrade (1995) classification.
  • 2.Patients who has quit the habit of areca nut.
  • 3.Patientsbelow 12 years of age and above 12 years of age.
  • 4.Patients with visual analog scale (VAS) score below 6
  • 5.Patients who were willing to participate in the study.

排除标准

  • 1.Individuals with history of treatment and undergoing treatment for oral submucous fibrosis.
  • 2.Patients with any oral or systemic diseases and/or any medications
  • 3.Patients diagnosed with grade IV cases of OSMF according to Khanna and Andrade classification.
  • 4.Pregnant and lactating women.
  • 5.Patients with VAS score above 6.
  • 6.History of hypersensitivity to bee products or any other medications.

研究者

发起方
Dr Divya Dube

相似试验

A clinical drug trial to study the effectiveness of... | 临床试验